Levi & Korsinsky on Dec. 16 announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Seadrill Limited (NYSE:SDRL) American Depository Receipts (“ADRs”) between July 10, 2014 and November 25, 2014. The complaint alleges that Seadrill issued materially false and misleading information to the investing public. SeaDrill Limited (NYSE:SDRL) in last trading activity advanced 1.94% to close at $12.60. Company weekly performance is 13.92% while its quarterly performance stands at -55.60%. SeaDrill Limited (NYSE:SDRL) is -67.99% away from its 52 week high.
ImmunoGen, Inc.(NASDAQ:IMGN) reported that Roche (OTC: RHHBY) has announced top-line results of its Phase III MARIANNE study. The study evaluated three HER2-targeted regimens Kadcyla® (ado-trastuzumab emtansine) plus Perjeta® (pertuzumab), Kadcyla alone, and Herceptin® (trastuzumab) plus taxane chemotherapy in people with previously untreated HER2-positive metastatic breast cancer (mBC). On last trading day ImmunoGen, Inc. (NASDAQ:IMGN) fell -43.69% to close at $6.11. Its volatility for the week is 11.22% while volatility for the month is 6.72%. IMGN’s sales growth for past 5 years was 16.40% and its EPS growth for past 5 years was -5.70%. ImmunoGen, Inc. (NASDAQ:IMGN) monthly performance is -34.37%.
Ariad Pharmaceuticals Inc (NASDAQ:ARIA) CEO Harvey J. M. D. Berger acquired 25,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, December 18th. The stock was purchased at an average price of $6.35 per share, for a total transaction of $158,750.00. Following the transaction, the chief executive officer now directly owns 1,163,564 shares of the company’s stock, valued at approximately $7,388,631. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) in last trading activity increased 9.23% to close at $7.22. Company weekly performance is 13.88% while its quarterly performance stands at 28.47%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) is -26.55% away from its 52 week high.
Independent Bank Group (NASDAQ:IBTX) Director John Webb Jennings III bought 1,500 shares of the stock in a transaction dated Thursday, December 18th. The stock was purchased at an average cost of $39.82 per share, with a total value of $59,730.00. Following the transaction, the director now directly owns 39,350 shares in the company, valued at approximately $1,566,917. Independent Bank Corporation (NASDAQ:IBCP) has 1.50% insider ownership while its institutional ownership stands at 75.20%. In last trading activity company’s stock closed at $12.71.
Shares of Polaris Industries Inc (NYSE:PII) have earned an average recommendation of “Buy” from the eight ratings firms that are covering the company, AnalystRatings.NET reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. On Friday shares of Polaris Industries Inc. (NYSE:PII) closed at $148.54. Company’s sales growth for last 5 years was 14.20% and EPS growth for next 5 years is recorded as 17.50%.